Pesquisas alternativas:
developp type » developing type (Expandir a Pesquisa), development type (Expandir a Pesquisa), developed ptypei (Expandir a Pesquisa)
dose develop » bse develop (Expandir a Pesquisa), mouse develops (Expandir a Pesquisa), sense develop (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
de developp » se developpe (Expandir a Pesquisa), de developing (Expandir a Pesquisa), le developper (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 1,742 para a pesquisa '(( drug de developp type ) OR ( drug dose develop type ))', tempo de pesquisa: 0.50seg Refinar resultados
Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials
Pharmacokinetics and Drug Dosing in Obese Children

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
Short Communication: A Repeated Simian Human Immunodeficiency Virus Reverse Transcriptase/Herpes Simplex Virus Type 2 Cochallenge Macaque Model for the Evaluation of Microbicides

Development of a mobile application for vancomycin dosing calculation: A useful tool for the rational use of antimicrobials
Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations

Oxazolone-Induced Delayed Type Hypersensitivity Reaction in the Adult Yucatan Pigs. A Useful Model for Drug Development and Validation
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs

Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response
Development of an Optimized Dose for Coformulation of Zidovudine with Drugs That Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model

Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia
Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes

Development of drug resistance in a murine mammary tumour.
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates

Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors
Drug related problems in elderly patients with type 2 diabetes mellitus

Alzheimer’s Disease Drug Development in 2008 and Beyond: Problems and Opportunities
Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments

Drug permeation and metabolism in Mycobacterium tuberculosis: prioritising local exposure as essential criterion in new TB drug development
Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges?

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa